FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

US Compounding MethylPREDNISolone Recall

MethylPREDNISolone (100 mg/mL) 10 mL Multi-Dose Vial, For IM & Regional Injection, Rx o…

US Compounding Inc · Conway, AR

Risk level
Class II
Reported by FDA
Nov 25, 2015
Recall ID
D-0265-2016
Check your lot numberHow we source this data

Summary

US Compounding recalled MethylPREDNISolone starting Sep 12, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0265-2016 on Nov 25, 2015. Reason: Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Product description

MethylPREDNISolone (100 mg/mL) 10 mL Multi-Dose Vial, For IM & Regional Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3115-07

Lot numbers, UPCs & expiration codes

Lot Numbers: 20150806@41 BUD: 12/5/2015, 20151205@67 BUD: 11/8/2015, 20151504@24 BUD: 10/12/2015, 20152306@30 BUD: 12/20/2015, 20152603@27 BUD: 9/22/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0265-2016
Classification
Class II
Status
Terminated
Recall initiated
Sep 12, 2015
FDA report date
Nov 25, 2015
Quantity
3,629 vials
Recall type
Voluntary: Firm initiated
Recalling firm
US Compounding Inc

Original FDA data

Every field from FDA enforcement report D-0265-2016, exactly as published.

Show all FDA fields
City
Conway
State
AR
Status
Terminated
Country
United States
Event ID
72179
Address
1270 Don's Lane
Code information
Lot Numbers: 20150806@41 BUD: 12/5/2015, 20151205@67 BUD: 11/8/2015, 20151504@24 BUD: 10/12/2015, 20152306@30 BUD: 12/20/2015, 20152603@27 BUD: 9/22/2015
Postal code
72032
Report date
Nov 25, 2015
Product type
Drugs
Recall number
D-0265-2016
Classification
Class II
Recalling firm
US Compounding Inc
Product quantity
3,629 vials
Termination date
Mar 30, 2017
Reason for recall
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
MethylPREDNISolone (100 mg/mL) 10 mL Multi-Dose Vial, For IM & Regional Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3115-07
Distribution pattern
Nationwide
Recall initiation date
Sep 12, 2015
Initial firm notification
Letter
Center classification date
Nov 17, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0265-2016, published Nov 25, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls